Ora-Blend

DRUG2 trials

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre, Pia Wintermark

Conditions

Neonatal Encephalopathy

Phase 1

Sildenafil Administration to Treat Neonatal Encephalopathy

CompletedNCT02812433

McGill University Health Centre/Research Institute of the McGill University Health CentreNeonatal Encephalopathy

Start: 2016-07-31End: 2022-01-31Updated: 2022-02-08

Phase 2

Treatment of Neonatal Encephalopathy With Oral Sildenafil Suspension to Repair Brain Injury Secondary to Birth Asphyxia

RecruitingNCT06098833

Pia WintermarkNeonatal Encephalopathy

Start: 2024-07-01End: 2031-10-01Target: 60Updated: 2026-09-17

Related Papers

Feasibility and Safety of Sildenafil to Repair Brain Injury Secondary to Birth Asphyxia (SANE-01): A Randomized, Double-blind, Placebo-controlled Phase Ib Clinical Trial.

2023-12-228 citations